Malignant lymphoma |
| |
| Authors: | Mori Tetsuya |
| |
| Institution: | Dept. of Strategic Medicine, Division of Pediatric Oncology, National Center for Child Health and Development. |
| |
| Abstract: | Based on the systematic improvements in treatment over recent decades, more than 70% of children and adolescents with non-Hodgkin lymphoma will survive at least 5 years with standard chemotherapy. This report highlights several advances in treatment for each histologic subtype of childhood non-Hodgkin lymphoma, focusing on published results of clinical trials from European and North American study groups. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
